PTON vs SPRY
Peloton Interactive Inc (PTON) versus ARS Pharmaceuticals, Inc (SPRY) — a side-by-side from cached financials, not a winner call.
Peloton Interactive Inc (PTON) is a leisure company listed on NASDAQ.
ARS Pharmaceuticals, Inc (SPRY) is a biotechnology company listed on NASDAQ.
Latest reported PTON revenue for 2025-06-30 was $2.49B. Net income was -$118.9M. Revenue was down 7.8% from 2024-06-30 to 2025-06-30. PTON currently screens at market cap $2.39B and trailing P/E 92.2.
Latest reported SPRY revenue for 2024-12-31 was $89.1M. Net income was $8.0M. Revenue was up 297063.3% from 2023-12-31 to 2024-12-31. SPRY currently screens at market cap $983.1M.
PTON currently screens at market cap $2.39B and trailing P/E 92.2. SPRY currently screens at market cap $983.1M.
Not investment advice. Open the PTON and SPRY stock pages for the full models.
Not investment advice.